Abstract
Dear EditorMLLT10 fusions, particularly with PICALM as fusion partner, hold prognostic or therapeutic significance as per European LeukemiaNet (ELN) and have been classified under ‘AML, along with ...

This publication has 11 references indexed in Scilit: